Spiro-imidazolidines as aldose reductase inhibitors and their ph

Details Spiro-imidazolidines as aldose reductase inhibitors and their ph Spiro-imidazolidines as aldose reductase inhibitors and their ph

1985-05-29

1986-03-11

Bond, Robert T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514389, 546 18, 548308, 548309, A61K 31415, C07D47110, C07D49107, C07D23378

Patent

active

045755078

ABSTRACT:
Compounds related to 3',4'-dihydrospiro[imidazolidine-4,1'(2'H)-naphthalene]2,3',5-trione, spiro[chroman-4,4'-imidazolidine]2,2',5'-trione and 1',2'-dihydrospiro[imidazolidine-4,4'-(3'H)-quinoline 2,2'5-trione and reduced products thereof as aldose reductase inhibitors.

REFERENCES:
patent: 4235911 (1980-11-01), Sarges
patent: 4540704 (1985-09-01), Ueda et al.

Affiliated with

Also associated with

Rating

Spiro-imidazolidines as aldose reductase inhibitors and their ph does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spiro-imidazolidines as aldose reductase inhibitors and their ph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-imidazolidines as aldose reductase inhibitors and their ph will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2191658